Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Phase I (clinic-based part of the trial):
- Women between the ages of 25 and 65
- People who already have a Pap smear appointment booked at Jefferson OBGYN Center City
- People who are willing and able to give their agreement to take part in the study
- People who agree to do an HPV self-collection procedure during the same clinic visit
- People who have not had a hysterectomy (an intact cervix is required)
Phase II (community outreach part of the trial — focused on minority groups who are under-screened):
- Women between the ages of 25 and 65
- People who have not had a Pap smear in the past 3 years (if under 30) or the past 5 years (if 30 or older), based on self-reported screening history
- People who identify as Hispanic, Black/African, Black Caribbean, Chinese, Korean, or Vietnamese
- People who are able to give informed consent in their preferred language
Who may not be able to join:
Phase I:
- People who are currently pregnant (whether self-reported or confirmed)
- People who have taken part in an HPV self-collection study in the past 12 months
- People who have visible signs of a vaginal or cervical infection, or symptoms suggesting a current genital tract infection
- People who are unable to follow study instructions or procedures (confirm with trial site)
Phase II:
- People who have a history of hysterectomy or cervical cancer
- People who have previously taken part in a cervical cancer screening study or other cancer prevention study
- People who are currently pregnant (self-reported)
- People who are unable to give informed consent
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sandra Dayaratna, MD, MBA, Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phone: 617-834-3894
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Diagnostic Concordance of Self-Collected vs. Clinically collected sample (Phase I); Feasibility of HPV Self-Collection: Completion of Self-Collection Kit
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.